Loncom Pharma's Anti-inflammatory APIs encompass a range of compounds like Celecoxib and Pranoprofen, each tailored to combat inflammation and pain. These APIs are the backbone of NSAIDs, offering relief from chronic conditions such as arthritis, and play a pivotal role in improving patient quality of life.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
